Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib

This study has been terminated.
(study terminated 12Feb09 due to low recruitment)
Sponsor:
Collaborators:
Princess Margaret Hospital, Canada
Mount Sinai Hospital, Canada
Novartis
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00461929
First received: April 16, 2007
Last updated: February 12, 2009
Last verified: April 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)